Your browser doesn't support javascript.
loading
Significantly Minimizing Drug Wastage and the Cost of Cabazitaxel Used to Treat Metastatic Castration-Resistant Prostate Cancer.
Jiang, Di Maria; Fallah-Rad, Nazanin; Lee, Roy; Ng, Pamela; Smith, Alan D; Hansen, Aaron R; Joshua, Anthony M; Beca, Jaclyn; Sridhar, Srikala S.
Afiliação
  • Jiang DM; Division of Medical Oncology, Department of Medicine, Princess Margaret Cancer Center, University Health Network, University of Toronto, Toronto, Ontario, Canada.
  • Fallah-Rad N; Division of Medical Oncology, Department of Medicine, Princess Margaret Cancer Center, University Health Network, University of Toronto, Toronto, Ontario, Canada.
  • Lee R; Department of Pharmacy, Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada.
  • Ng P; Department of Pharmacy, Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada.
  • Smith AD; Division of Medical Oncology, Department of Medicine, Princess Margaret Cancer Center, University Health Network, University of Toronto, Toronto, Ontario, Canada.
  • Hansen AR; Division of Medical Oncology, Department of Medicine, Princess Margaret Cancer Center, University Health Network, University of Toronto, Toronto, Ontario, Canada.
  • Joshua AM; Division of Medical Oncology, Department of Medicine, Princess Margaret Cancer Center, University Health Network, University of Toronto, Toronto, Ontario, Canada; Department of Medical Oncology, Kinghorn Cancer Centre, St. Vincent's Hospital, Darlinghurst, Australia.
  • Beca J; Pharmacoeconomics Research Unit, Cancer Care Ontario, Toronto, Ontario, Canada.
  • Sridhar SS; Division of Medical Oncology, Department of Medicine, Princess Margaret Cancer Center, University Health Network, University of Toronto, Toronto, Ontario, Canada. Electronic address: srikala.sridhar@uhn.ca.
Eur Urol ; 79(2): 177-179, 2021 02.
Article em En | MEDLINE | ID: mdl-33461737

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Custos de Medicamentos / Redução de Custos / Taxoides / Neoplasias de Próstata Resistentes à Castração Tipo de estudo: Health_economic_evaluation Limite: Humans / Male Idioma: En Revista: Eur Urol Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Canadá

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Custos de Medicamentos / Redução de Custos / Taxoides / Neoplasias de Próstata Resistentes à Castração Tipo de estudo: Health_economic_evaluation Limite: Humans / Male Idioma: En Revista: Eur Urol Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Canadá